Eckert and Ziegler

Eckert & Ziegler is a German specialty company and a global leader in the application of isotope technology, with a mission encapsulated by 'We help to heal.' The company has established itself as a key infrastructure player in nuclear medicine, supplying critical components for cancer therapy (e.g., brachytherapy, targeted radionuclide therapy) and diagnostics. Its strategy focuses on vertical integration across the isotope value chain—from production and processing to distribution and services—while expanding geographically through strategic acquisitions to solidify its market position.

Integrated suite of capabilities across the isotope technology value chain, including isotope production & processing, brachytherapy device manufacturing, targeted radionuclide therapy support, and global radiation services & logistics.

EZAG competes in oligopolistic markets with high barriers to entry. In isotope supply, it faces state-owned entities and a few large private players. In brachytherapy, it competes with giants like Elekta and Siemens. Its competitive moat is built on vertical integration, deep regulatory expertise, and a diversified global footprint.